Ultraviolet radiation and melanoma: A systematic review and analysis of reported sequence variants

Human Mutation

Volumn 28, Issue 6, 2007, Pages 578-588

  Hocker, Thomas ^a   Tsao, Hensin ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer; Melanoma; Meta analysis; Mutation

Indexed keywords

CARCINOGENESIS; DATA BASE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MELANOMA; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

DNA MUTATIONAL ANALYSIS; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; MUTATION; NEOPLASMS, RADIATION-INDUCED; PROTO-ONCOGENES; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UVEAL NEOPLASMS;

EID: 34248375532     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20481     Document Type: Review

References (22)

1. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. 2004. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 101:4954-4959.
2. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128.
3. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocket EB, LeBoit PE, Pinkel D, Bastian BC. 2005. Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-2147.
4. Curtin JA, Busam K, Pinkel D, Bastian BC. 2006. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340-4346.
5. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954.
6. den Dunnen JT, Antonarakis SE. 2001. Nomenclature for the description of human sequence variations. Hum Genet 109:121-124.
7. Elwood JM. 1996. Melanoma and sun exposure. Semin Oncol 23:650-666.
8. Giglia-Mari G, Sarasin A. 2003. TP53 mutations in human skin cancers. Hum Mutat 21:217-228.
9. Gilchrest BA, Eller MS, Geller AC, Yaar M. 1999. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348.
10. Kraemer KH, Lee MM, Scotto J. 1984. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 5:511-514.
11. Kraemer KH, Levy DD, Parris CN, Gozukara EM, Moriwaki S, Adelberg S, Seidman MM. 1994. Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer. J Invest Dermatol 103(Suppl):96S-101S.
12. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. 2003. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-1890.
13. Murphy JA, Barrantes-Reynolds R, Kocherlakota R, Bond JP, Greenblatt MS. 2004. The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association. Hum Mutat 24: 296-304.
14. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y. 2006. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 38:294-296.
15. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
16. Petti C, Molla A, Vegetti C, Ferrone S, Anichini A, Sensi M. 2006. Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity. Cancer Res 66:6503-6511.
17. Popat S, Houlston RS. 2005. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41:2060-2070.
18. Rivers JK. 2004. Is there more than one road to melanoma? Lancet 363: 728-730.
19. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, Wolff RK, Slattery ML. 2005. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65:6063-6069.
20. Sensi M, Nicolini G, Zanon M, Colombo C, Molla A, Bersani I, Lupetti R, Parmiani G, Anichini A. 2005. Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype. Cancer Res 65:632-640.
21. Tsao H, Sober AJ. 1998. Ultraviolet radiation and malignant melanoma. Clin Dermatol 16:67-73.
22. Tsao H, Atkins MB, Sober AJ. 2004. Management of cutaneous melanoma. N Engl J Med 351:998-1012.